About IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences is a company based in Thunder Bay (Canada) founded in 2009.. IgY Immune Technologies & Life Sciences has raised $65.1 thousand across 1 funding round. IgY Immune Technologies & Life Sciences offers products and services including Muno-IgY. IgY Immune Technologies & Life Sciences operates in a competitive market with competitors including Newtricious, Microcore, BiovaBIO and Nutriom, among others.
- Headquarter Thunder Bay, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Igy Immune Technologies And Life Sciences Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$65.1 K (USD)
in 1 rounds
-
Latest Funding Round
$65.1 K (USD), Seed
Feb 17, 2012
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences offers a comprehensive portfolio of products and services, including Muno-IgY. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Purified IgY protein for immune and gut health support
Funding Insights of IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences has successfully raised a total of $65.1K through 1 strategic funding round. The most recent funding activity was a Seed round of $65.1 thousand completed in February 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $65,100
-
First Round
First Round
(17 Feb 2012)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2012 | Amount | Seed - IgY Immune Technologies & Life Sciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by IgY Immune Technologies & Life Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - IgY Immune Technologies Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Igy Immune Technologies & Life Sciences Comparisons
Competitors of IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newtricious, Microcore, BiovaBIO and Nutriom, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Egg-based active ingredients are supplied for functional foods.
|
|
| domain | founded_year | HQ Location |
Develops and manufactures nutritional ingredients and medical foods for health applications.
|
|
| domain | founded_year | HQ Location |
Provides nutrients from eggshell membrane for skin and hair health support.
|
|
| domain | founded_year | HQ Location |
Manufactures high-quality egg white protein powder for health-conscious consumers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Igy Immune Technologies & Life Sciences
Frequently Asked Questions about IgY Immune Technologies & Life Sciences
When was IgY Immune Technologies & Life Sciences founded?
IgY Immune Technologies & Life Sciences was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Where is IgY Immune Technologies & Life Sciences located?
IgY Immune Technologies & Life Sciences is headquartered in Thunder Bay, Canada. It is registered at Thunder Bay, Ontario, Canada.
Who is the current CEO of IgY Immune Technologies & Life Sciences?
Terry Dyck is the current CEO of IgY Immune Technologies & Life Sciences.
Is IgY Immune Technologies & Life Sciences a funded company?
IgY Immune Technologies & Life Sciences is a funded company, having raised a total of $65.1K across 1 funding round to date. The company's 1st funding round was a Seed of $65.1K, raised on Feb 17, 2012.
What does IgY Immune Technologies & Life Sciences do?
IgY Immune Technologies Life Sciences was founded in 2009 in Thunder Bay, Canada, focusing on biotechnology. Polyclonal IgY antibodies are derived from chicken eggs for human and animal applications in nutraceuticals and pharmaceuticals. These products support sectors including medicine, functional foods, agriculture, and cosmeceuticals, with non-specific types used in general supplements and specific types targeted at vaccine-resistant pathogens. The company was deemed deadpooled as of March 2018.
Who are the top competitors of IgY Immune Technologies & Life Sciences?
IgY Immune Technologies & Life Sciences's top competitors include Newtricious, Microcore and BiovaBIO.
What products or services does IgY Immune Technologies & Life Sciences offer?
IgY Immune Technologies & Life Sciences offers Muno-IgY.